Live Web Chat: Answering Questions on New Lymphoma Treatments


Ann LaCasce, MD, a medical oncologist in the Dana-Farber/Brigham and Women’s Cancer Center Adult Lymphoma Program, answered a variety of questions about Hodgkin and non-Hodgkin lymphoma during a live web chat hosted by Dana-Farber last month.

The chat, which featured questions submitted by patients and live viewers, focused on new treatments for lymphoma. Some of the topics discussed included new drugs Ibrutinib and Brentuximab, use of umbilical cord stem cells, and treatments with genetically engineered T-cells.

“There are some questions we still have, but I think the work around T-cells is a very exciting area in lymphoma, and it’s going to have applications in other cancers as well,” LaCasce said.

View a video of the Dec. 18 web chat below. For more information on lymphoma, visit the Dana-Farber Adult Lymphoma Program website.

Comments Sort By Newest

Leave a Reply

Your email address will not be published. Required fields are marked *

Blue Captcha Image


Latest Tweets

Dana-Farber @danafarber
How Expressive Arts Help Patients Cope with #Cancer:
Dana-Farber @danafarber
Maintaining a Healthy Weight May Be the Best Thing You Can Do to Eliminate Cancer Risk: #nutrition
Dana-Farber @danafarber
Dr. Lisa Diller Discusses Five Things Female Childhood Cancer Survivors Should Know: #pedcsm

Make An Appointment

For adults: 877-442-3324

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.